Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/KUR stock hub

FRA/KUR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/KURis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

710.4M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/KURFRA/KUR

—

Loading chart…

In the news

Latest news · FRA/KUR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-94.8

P25 n/aP50 n/aP75 n/a

ROIC-60.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/KUR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

USD

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	260
Employees Change	68%
Employees Change Percent	35.42
Enterprise value	EUR 160.9M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 710.4M
Price	EUR 7.86
Price currency	EUR
Rev Per Employee	221,055.46x
Sic	2836
Symbol	fra/KUR
Website	https://kuraoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-33.41%
EV Earnings	-0.68x
EV/FCF	-2.67x
EV/Sales	2.81x
FCF yield	-8.48%
P/B ratio	4.79x
P/S ratio	12.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-272.15%
Gross Profit	EUR -156.4M
Net Income	EUR -237.3M
Pretax Margin	-412.51%
Profit Per Employee	EUR -912,846
ROA	-25.33
Roa5y	-19.95
ROCE	-48.86
ROE	-94.82
Roe5y	-45.55
ROIC	-60.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.6%
Cagr1y	57.19%
Cagr3y	-8.02%
Cagr5y	-17.53%
FCF Growth Q	-57.23%
OCF Growth Q	-56.43%
Revenue Growth	25.24x
Revenue Growth Q	-67.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.09
Assets	EUR 628.9M
Cash	EUR 568.3M
Current Assets	EUR 600.9M
Current Liabilities	EUR 99.2M
Debt	EUR 17.4M
Debt Equity	EUR 0.12
Debt FCF	EUR -0.29
Equity	EUR 148.3M
Interest Coverage	-200.8
Liabilities	EUR 480.6M
Long Term Assets	EUR 27.9M
Long Term Liabilities	EUR 381.4M
Net Cash	EUR 550.9M
Net Cash By Market Cap	EUR 77.54
Net Cash Growth	-9.01%
Net Debt Equity	EUR -3.71
Tangible Book Value	EUR 148.3M
Tangible Book Value Per Share	EUR 1.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.06
Net Working Capital	EUR -63.3M
Quick ratio	5.81
Working Capital	EUR 503.9M
Working Capital Turnover	EUR 0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	227.5%
1Y total return	57.14%
200-day SMA	7.58
3Y total return	-22.18%
50-day SMA	7.43
50-day SMA vs 200-day SMA	50under200
5Y total return	-61.84%
All Time High	34.4
All Time High Change	-77.15%
All Time High Date	2020-12-14
All Time Low	2.28
All Time Low Change	245.19%
All Time Low Date	2016-06-24
ATR	0.18
Ch YTD	-9.76
High	7.86
High52	10.78
High52 Date	2025-11-14
High52ch	-27.05%
Low	7.86
Low52	4.68
Low52 Date	2025-08-12
Low52ch	67.91%
Ma50ch	5.77%
Price vs 200-day SMA	3.67%
RSI	55.48
RSI Monthly	44.93
RSI Weekly	52.64
Sharpe ratio	0.88x
Sortino ratio	1.54
Total Return	-1.76%
Tr YTD	-9.76
Tr1m	8.86%
Tr1w	6.5%
Tr3m	23.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -258.6M
Operating margin	-449.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65,275,666%
Shares Insiders	1.53%
Shares Institutions	72.79%
Shares Qo Q	0.46%
Shares Yo Y	1.76%
Short Ratio	10.51

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -91.8M
Average Volume	1x
Bv Per Share	1.69
CAPEX	EUR -5.7M
Ch10y	227.5
Ch1m	8.86
Ch1w	6.5
Ch1y	57.14
Ch3m	23.12
Ch3y	-22.18
Ch5y	-61.84
Ch6m	-12.45
Change	-2.48%
Change From Open	0
Close	8.06
Days Gap	-2.48
Depreciation Amortization	875,096.8
Earnings Date	2026-05-12
EBIT	EUR -258.6M
EBITDA	EUR -257.7M
EPS	EUR -2.71
F Score	2
FCF	EUR -60.2M
FCF EV Yield	-37.43x
Financing CF	1,527,098
Fiscal Year End	December
Income Tax	EUR 252,955
Investing CF	-11,155,567
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	8.01
Ma150ch	-1.92%
Ma20	7.7
Ma20ch	2.09%
Net CF	-64,186,667
Next Earnings Date	2026-05-12
Open	7.86
Ppne	12,852,560
Price Date	2026-05-08
Ptbv Ratio	4.79
Relative Volume	20x
Revenue	57,474,419x
SBC By Revenue	54.99x
Share Based Comp	31,604,884
Tax By Revenue	0.44x
Tr6m	-12.45%
Volume	0
Z Score	-1.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/KUR pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/KUR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/KUR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+72.8%

Share of float held by funds and institutions

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/KUR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.5

Neutral momentum band

Price vs 200-day MA

+3.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/KUR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/KUR stock rating?

fra/KUR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/KUR analysis?

The full report lives at /stocks/fra/KUR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/KUR?

The latest report frames fra/KUR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/KUR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.